| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| General | 6,000 | 6,000 | 0 | 6,000 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | 1994-02 | Purchase | 2024-04 |
BristolMyers Squibb |
177,276 | 55,293 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 8900 JP Morgan | 292,017 | 1,803,407 |
| 4500 Philip Morris | 40,287 | 456,210 |
| 15000 US Bancorp | 440,006 | 608,250 |
| 19000Bristol-Meyers Squibb | 233,808 | 616,350 |
| 84304.214 American Income Fund | 1,492,333 | 2,041,848 |
| 4132.915 American Capital Income | 252,066 | 284,517 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| General Counsel | 41,512 | 41,512 | 0 | 41,512 |
| Description | Amount |
|---|---|
| Book value reduced by sale of stock | 70,962 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Excise Tax | 1,596 | 1,596 | 0 | 1,596 |